Suppr超能文献

基于变构探针的磁珠 DNA 合成用于癌胚抗原检测。

On-bead DNA synthesis triggered by allosteric probe for detection of carcinoembryonic antigen.

机构信息

Key Laboratory of Longevity and Aging-Related Diseases of Chinese Ministry of Education, Guangxi Colleges and Universities Key Laboratory of Biological Molecular Medicine Research, School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.

College of Chemistry, Fuzhou University, Fuzhou, Fujian, 350108, People's Republic of China.

出版信息

Mikrochim Acta. 2022 Aug 1;189(8):305. doi: 10.1007/s00604-022-05404-4.

Abstract

Sensitive quantification of protein biomarkers is highly desired for clinical diagnosis and treatment. Yet, unlike DNA/RNA which can be greatly amplified by PCR/RT-PCR, the amplification and detection of trace amount of proteins remain a great challenge. Here, we combined allosteric probe (AP) with magnetic bead (MB) for assembling an on-bead DNA synthesis system (named as APMB) to amplify protein signals. The AP is designed and conjugated onto the MB, enabling the protein biomarker to be separated and enriched. Once recognizing the biomarker, the AP alters its conformation to initiate DNA synthesis on beads for primary signal amplification. During the DNA synthesis, biotin-dATPs are incorporated into the newly synthesized DNA strands. Then, the biotin-labeled DNA specifically captures streptavidin (STR)-conjugated horseradish peroxidase (HRP), which is used to catalyze a colorimetric reaction for secondary signal amplification. By using carcinoembryonic antigen (CEA) as a protein model, the APMB can quantify protein biomarkers of as low as 0.01 ng/mL. The response values measured by APMB are linearly related to the protein concentrations in the range 0.05 to 20 ng/mL. Clinical examination demonstrated good practicability of the APMB in quantifying serum protein biomarker. The on-bead DNA synthesis could be exploited to improve protein signal amplification, thus facilitating protein biomarker detection of low abundance for early diagnosis.

摘要

对蛋白质生物标志物进行灵敏的定量分析对于临床诊断和治疗非常重要。然而,与可以通过 PCR/RT-PCR 大大扩增的 DNA/RNA 不同,痕量蛋白质的扩增和检测仍然是一个巨大的挑战。在这里,我们将变构探针 (AP) 与磁珠 (MB) 结合起来,组装成一种在珠上的 DNA 合成系统(称为 APMB),以扩增蛋白质信号。AP 被设计并连接到 MB 上,使蛋白质生物标志物能够被分离和富集。一旦识别出生物标志物,AP 就会改变其构象,在珠上启动 DNA 合成以进行初级信号放大。在 DNA 合成过程中,生物素-dATP 被掺入新合成的 DNA 链中。然后,生物素标记的 DNA 特异性捕获链霉亲和素 (STR) 偶联的辣根过氧化物酶 (HRP),后者用于催化比色反应以进行二级信号放大。通过使用癌胚抗原 (CEA) 作为蛋白质模型,APMB 可以定量低至 0.01 ng/mL 的蛋白质生物标志物。APMB 测量的响应值与 0.05 至 20 ng/mL 范围内的蛋白质浓度呈线性相关。临床检查证明了 APMB 在定量血清蛋白生物标志物方面的良好实用性。在珠上的 DNA 合成可以用来提高蛋白质信号的放大,从而促进低丰度蛋白质生物标志物的检测,实现早期诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/442f/9342938/a423a45c578e/604_2022_5404_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验